{
 "schema_version": "014.v1",
 "company": {
  "company_id": "co:cik:0000872589",
  "name": "REGENERON PHARMACEUTICALS, INC.",
  "names": [
   {
    "name": "REGENERON PHARMACEUTICALS, INC.",
    "kind": "legal",
    "evidence": {
     "source": "SEC EDGAR",
     "source_url": "https://seraphixsystems.com/org/sx%3Asec%3A0000872589",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "name": "REGENERON PHARMACEUTICALS INC",
    "kind": "former",
    "evidence": {
     "source": "SEC EDGAR",
     "source_url": "https://seraphixsystems.com/org/sx%3Asec%3A0000872589",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "name": "REGENERON INDIA PRIVATE LIMITED",
    "kind": "legal",
    "evidence": {
     "source": "gleif_lei",
     "source_url": "https://seraphixsystems.com/org/sx%3Alei%3A335800DYBVNUYLGVHJ55",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "name": "REGENERON IRELAND DESIGNATED ACTIVITY COMPANY",
    "kind": "legal",
    "evidence": {
     "source": "gleif_lei",
     "source_url": "https://seraphixsystems.com/org/sx%3Alei%3A635400NABUOXXFAMHX81",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   }
  ],
  "granularity": "LEGAL_ENTITY",
  "identifiers": [
   {
    "type": "CIK",
    "value": "872589",
    "join": "id",
    "join_method": "id:sec-anchor",
    "registry_url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589",
    "evidence": {
     "source": "SEC EDGAR",
     "source_url": "https://seraphixsystems.com/org/sx%3Asec%3A0000872589",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "TICKER",
    "value": "REGN",
    "join": "id",
    "join_method": "SEC company record",
    "registry_url": "https://data.sec.gov/submissions/CIK0000872589.json",
    "evidence": {
     "source": "SEC EDGAR",
     "source_url": "https://data.sec.gov/submissions/CIK0000872589.json",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "LEI",
    "value": "335800DYBVNUYLGVHJ55",
    "join": "id",
    "join_method": "id:lei-family",
    "registry_url": "https://search.gleif.org/#/record/335800DYBVNUYLGVHJ55",
    "evidence": {
     "source": "GLEIF",
     "source_url": "https://search.gleif.org/#/record/335800DYBVNUYLGVHJ55",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "LEI",
    "value": "635400NABUOXXFAMHX81",
    "join": "id",
    "join_method": "id:lei-family",
    "registry_url": "https://search.gleif.org/#/record/635400NABUOXXFAMHX81",
    "evidence": {
     "source": "GLEIF",
     "source_url": "https://search.gleif.org/#/record/635400NABUOXXFAMHX81",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "LEI",
    "value": "549300RCBFWIRX3HYQ56",
    "join": "id",
    "join_method": "id:lei-family",
    "registry_url": "https://search.gleif.org/#/record/549300RCBFWIRX3HYQ56",
    "evidence": {
     "source": "GLEIF",
     "source_url": "https://search.gleif.org/#/record/549300RCBFWIRX3HYQ56",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "EIN",
    "value": "133444607",
    "join": "id",
    "join_method": "carried on the SEC-anchored record",
    "registry_url": null,
    "evidence": {
     "source": "SEC EDGAR / IRS",
     "source_url": "https://seraphixsystems.com/org/sx%3Asec%3A0000872589",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "CUSIP",
    "value": "75886F107",
    "join": "id",
    "join_method": "carried on the SEC-anchored record",
    "registry_url": null,
    "evidence": {
     "source": "SEC EDGAR",
     "source_url": "https://seraphixsystems.com/org/sx%3Asec%3A0000872589",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "UEI",
    "value": "N3F9MH7E6HD6",
    "join": "id",
    "join_method": "carried on the SEC-anchored record",
    "registry_url": null,
    "evidence": {
     "source": "USAspending",
     "source_url": "https://seraphixsystems.com/org/sx%3Asec%3A0000872589",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "LDA_CLIENT",
    "value": "65271",
    "join": "possible_match",
    "join_method": "name-exact:legal-name",
    "registry_url": "https://seraphixsystems.com/org/sx%3Alda%3A65271",
    "evidence": {
     "source": "Lobbying Disclosure Act (LDA)",
     "source_url": "https://seraphixsystems.com/org/sx%3Alda%3A65271",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "LDA_CLIENT",
    "value": "200807",
    "join": "possible_match",
    "join_method": "name-exact:legal-name",
    "registry_url": "https://seraphixsystems.com/org/sx%3Alda%3A200807",
    "evidence": {
     "source": "Lobbying Disclosure Act (LDA)",
     "source_url": "https://seraphixsystems.com/org/sx%3Alda%3A200807",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "LDA_CLIENT",
    "value": "210738",
    "join": "possible_match",
    "join_method": "name-exact:legal-name",
    "registry_url": "https://seraphixsystems.com/org/sx%3Alda%3A210738",
    "evidence": {
     "source": "Lobbying Disclosure Act (LDA)",
     "source_url": "https://seraphixsystems.com/org/sx%3Alda%3A210738",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "LDA_CLIENT",
    "value": "67618",
    "join": "possible_match",
    "join_method": "name-exact:legal-name",
    "registry_url": "https://seraphixsystems.com/org/sx%3Alda%3A67618",
    "evidence": {
     "source": "Lobbying Disclosure Act (LDA)",
     "source_url": "https://seraphixsystems.com/org/sx%3Alda%3A67618",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "LDA_CLIENT",
    "value": "208641",
    "join": "possible_match",
    "join_method": "name-exact:legal-name",
    "registry_url": "https://seraphixsystems.com/org/sx%3Alda%3A208641",
    "evidence": {
     "source": "Lobbying Disclosure Act (LDA)",
     "source_url": "https://seraphixsystems.com/org/sx%3Alda%3A208641",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "LDA_CLIENT",
    "value": "64079",
    "join": "possible_match",
    "join_method": "name-exact:legal-name",
    "registry_url": "https://seraphixsystems.com/org/sx%3Alda%3A64079",
    "evidence": {
     "source": "Lobbying Disclosure Act (LDA)",
     "source_url": "https://seraphixsystems.com/org/sx%3Alda%3A64079",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "LDA_CLIENT",
    "value": "196249",
    "join": "possible_match",
    "join_method": "name-exact:legal-name",
    "registry_url": "https://seraphixsystems.com/org/sx%3Alda%3A196249",
    "evidence": {
     "source": "Lobbying Disclosure Act (LDA)",
     "source_url": "https://seraphixsystems.com/org/sx%3Alda%3A196249",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "LDA_CLIENT",
    "value": "162758",
    "join": "possible_match",
    "join_method": "name-exact:legal-name",
    "registry_url": "https://seraphixsystems.com/org/sx%3Alda%3A162758",
    "evidence": {
     "source": "Lobbying Disclosure Act (LDA)",
     "source_url": "https://seraphixsystems.com/org/sx%3Alda%3A162758",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "FRS",
    "value": "110070120473",
    "join": "possible_match",
    "join_method": "name-exact",
    "registry_url": "https://seraphixsystems.com/org/sx%3Aepa%3A110070120473",
    "evidence": {
     "source": "EPA ECHO facilities",
     "source_url": "https://seraphixsystems.com/org/sx%3Aepa%3A110070120473",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "FRS",
    "value": "110071679215",
    "join": "possible_match",
    "join_method": "name-exact:legal-name",
    "registry_url": "https://seraphixsystems.com/org/sx%3Aepa%3A110071679215",
    "evidence": {
     "source": "EPA ECHO facilities",
     "source_url": "https://seraphixsystems.com/org/sx%3Aepa%3A110071679215",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "FRS",
    "value": "110014446894",
    "join": "possible_match",
    "join_method": "name-exact:legal-name",
    "registry_url": "https://seraphixsystems.com/org/sx%3Aepa%3A110014446894",
    "evidence": {
     "source": "EPA ECHO facilities",
     "source_url": "https://seraphixsystems.com/org/sx%3Aepa%3A110014446894",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "FRS",
    "value": "110000880887",
    "join": "possible_match",
    "join_method": "name-exact:legal-name",
    "registry_url": "https://seraphixsystems.com/org/sx%3Aepa%3A110000880887",
    "evidence": {
     "source": "EPA ECHO facilities",
     "source_url": "https://seraphixsystems.com/org/sx%3Aepa%3A110000880887",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "FRS",
    "value": "110071845659",
    "join": "possible_match",
    "join_method": "name-exact:legal-name",
    "registry_url": "https://seraphixsystems.com/org/sx%3Aepa%3A110071845659",
    "evidence": {
     "source": "EPA ECHO facilities",
     "source_url": "https://seraphixsystems.com/org/sx%3Aepa%3A110071845659",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   },
   {
    "type": "FRS",
    "value": "110071067985",
    "join": "possible_match",
    "join_method": "name-exact:legal-name",
    "registry_url": "https://seraphixsystems.com/org/sx%3Aepa%3A110071067985",
    "evidence": {
     "source": "EPA ECHO facilities",
     "source_url": "https://seraphixsystems.com/org/sx%3Aepa%3A110071067985",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   }
  ],
  "addresses": [
   {
    "kind": "business",
    "text": "777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591",
    "country": "US",
    "evidence": {
     "source": "SEC EDGAR company profile",
     "source_url": "https://data.sec.gov/submissions/CIK0000872589.json",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   }
  ],
  "classifications": [
   {
    "scheme": "SIC",
    "code": "2834",
    "description": "Pharmaceutical Preparations",
    "evidence": {
     "source": "SEC EDGAR company profile",
     "source_url": "https://data.sec.gov/submissions/CIK0000872589.json",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   }
  ],
  "status": [
   {
    "registry": "SEC EDGAR filer type",
    "status": "operating",
    "evidence": {
     "source": "SEC EDGAR company profile",
     "source_url": "https://data.sec.gov/submissions/CIK0000872589.json",
     "filing_id": null,
     "filed_date": null,
     "retrieved_at": "2026-11-21T11:33:17Z",
     "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
    }
   }
  ]
 },
 "facts": [
  {
   "section": "filed_figures",
   "label": "SEC entity type",
   "value": "operating",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR company profile",
    "source_url": "https://data.sec.gov/submissions/CIK0000872589.json",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "SIC industry",
   "value": "2834 Pharmaceutical Preparations",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR company profile",
    "source_url": "https://data.sec.gov/submissions/CIK0000872589.json",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "State of incorporation",
   "value": "NY",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR company profile",
    "source_url": "https://data.sec.gov/submissions/CIK0000872589.json",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Fiscal year end (MMDD)",
   "value": "1231",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR company profile",
    "source_url": "https://data.sec.gov/submissions/CIK0000872589.json",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Business address",
   "value": "777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR company profile",
    "source_url": "https://data.sec.gov/submissions/CIK0000872589.json",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Exchanges",
   "value": "Nasdaq",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR company profile",
    "source_url": "https://data.sec.gov/submissions/CIK0000872589.json",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Revenue (fiscal year ended 2025-12-31)",
   "value": 14342900000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Net income (loss) (fiscal year ended 2025-12-31)",
   "value": 4504900000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL NetIncomeLoss",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Total assets (at 2025-12-31)",
   "value": 40558700000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL Assets",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Stockholders' equity (at 2025-12-31)",
   "value": 31256900000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL StockholdersEquity",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Cash and cash equivalents (at 2025-12-31)",
   "value": 3118100000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL CashAndCashEquivalentsAtCarryingValue",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Operating cash flow (fiscal year ended 2025-12-31)",
   "value": 4978900000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL NetCashProvidedByUsedInOperatingActivities",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)",
   "value": 898400000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL PaymentsToAcquireProductiveAssets",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Long-term debt (at 2025-12-31)",
   "value": 1985900000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL LongTermDebtNoncurrent",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Operating lease liabilities (at 2025-12-31)",
   "value": 266800000,
   "unit": "USD",
   "period_start": null,
   "period_end": "2025-12-31",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "10-K, XBRL OperatingLeaseLiability",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Plan (pension, plan no. 001)",
   "value": "REGENERON PHARMACEUTICALS, INC. 401(K) SAVINGS PLAN: 14,387 participants, assets $3,199,977,583",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "DOL EBSA Form 5500 public datasets (dataset)",
    "source_url": "https://www.dol.gov/agencies/ebsa/about-ebsa/our-activities/public-disclosure/foia/form-5500-datasets",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Plan (welfare, plan no. 501)",
   "value": "REGENERON PHARMACEUTICALS, INC. WELFARE BENEFIT PLAN: 11,716 participants",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "DOL EBSA Form 5500 public datasets (dataset)",
    "source_url": "https://www.dol.gov/agencies/ebsa/about-ebsa/our-activities/public-disclosure/foia/form-5500-datasets",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Federal award transactions, fiscal year 2026 (this one registration only)",
   "value": 279399579.88,
   "unit": "USD",
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "USAspending recipient profile",
    "source_url": "https://www.usaspending.gov/recipient/a93bbddb-f028-4591-f6f4-06210cfeb656-C/latest",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Number of federal award transactions, fiscal year 2026 (this one registration only)",
   "value": 15,
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "USAspending recipient profile",
    "source_url": "https://www.usaspending.gov/recipient/a93bbddb-f028-4591-f6f4-06210cfeb656-C/latest",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Latest 10-Q: Revenue",
   "value": 5115800000,
   "unit": "USD",
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/",
    "filing_id": "0000872589-26-000034",
    "filed_date": "2026-10-30",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Latest 10-Q: Net income (loss)",
   "value": 1948700000,
   "unit": "USD",
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/",
    "filing_id": "0000872589-26-000034",
    "filed_date": "2026-10-30",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Latest 10-Q: Interest expense",
   "value": 10600000,
   "unit": "USD",
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/",
    "filing_id": "0000872589-26-000034",
    "filed_date": "2026-10-30",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Latest 10-Q: Cash and cash equivalents",
   "value": 3659100000,
   "unit": "USD",
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/",
    "filing_id": "0000872589-26-000034",
    "filed_date": "2026-10-30",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Latest 10-Q: Contract liabilities, current",
   "value": 749800000,
   "unit": "USD",
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/",
    "filing_id": "0000872589-26-000034",
    "filed_date": "2026-10-30",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "filed_figures",
   "label": "Latest 10-Q: Contract liabilities, noncurrent",
   "value": 220200000,
   "unit": "USD",
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/",
    "filing_id": "0000872589-26-000034",
    "filed_date": "2026-10-30",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "timeline",
   "label": "8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-10-30)",
   "value": "On October 30, 2026, Regeneron Pharmaceuticals, Inc. issued a press release announcing its financial and operating results for the quarter ended September 30, 2026. A copy of the press release is being furnished to the Securities and Exchange Commission as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference to this Item 2.02. The information included or incorporated in this Item 2.02, including Exhibit 99.1, shall not be deemed \"filed\" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall such information and exhibit be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall…",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR 8-K 0000872589-26-000032 (text as filed, excerpt)",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000032/regn-20261030.htm",
    "filing_id": null,
    "filed_date": "2026-10-30",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "timeline",
   "label": "8-K Item 1.01, Entry into a Material (filed 2026-10-06)",
   "value": "Definitive Agreement. On October 1, 2026, Regeneron Pharmaceuticals, Inc., a New York corporation (“Regeneron” or the “Company”), Sanofi Biotechnology SAS, a société par actions simplifée organized under the laws of France (“Sanofi Biotechnology”), and Sanofi, a société anonyme organized under the laws of France (“Sanofi Parent” and, with Sanofi Biotechnology, “Sanofi”), entered into the Sixth Amendment to the Amended and Restated License and Collaboration Agreement (the “Sixth Amendment”), which amends the Amended and Restated License and Collaboration Agreement, dated as of November 10, 2009 (as amended), by and between the Company, Sanofi Biotechnology (as successor in interest to…",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR 8-K 0001104659-26-113895 (text as filed, excerpt)",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926113895/tm2627077d1_8k.htm",
    "filing_id": null,
    "filed_date": "2026-10-06",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "timeline",
   "label": "8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-10-06)",
   "value": "Regeneron currently expects that its financial results calculated in accordance with U.S. generally accepted accounting principles (“GAAP”) and its non-GAAP financial results for the third quarter 2026 will include an acquired in-process research and development (“IPR&D”) charge of approximately $22 million on a pre-tax basis. The acquired IPR&D charge is expected to negatively impact each of GAAP and non-GAAP net income per diluted share for the third quarter 2026 by approximately $0.18. Acquired IPR&D charges may include IPR&D acquired in connection with asset acquisitions as well as up-front, opt-in, and development milestone payments and premiums paid on equity securities related to…",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR 8-K 0001104659-26-113895 (text as filed, excerpt)",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926113895/tm2627077d1_8k.htm",
    "filing_id": null,
    "filed_date": "2026-10-06",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "timeline",
   "label": "8-K Item 8.01, Other Events (filed 2026-10-06)",
   "value": "In connection with the execution of the Sixth Amendment, Regeneron and Sanofi entered into a settlement agreement pursuant to which Regeneron agreed to dismiss its lawsuit concerning Sanofi’s obligation to provide Regeneron with full access to material information relating to the commercialization of Dupixent® (dupilumab) and other products commercialized pursuant to the Antibody LCA, and Regeneron’s audit rights under the Antibody LCA. Note Regarding Forward-Looking Statements This Current Report on Form 8-K (this “Report”) includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron, and actual events or results…",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR 8-K 0001104659-26-113895 (text as filed, excerpt)",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926113895/tm2627077d1_8k.htm",
    "filing_id": null,
    "filed_date": "2026-10-06",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "timeline",
   "label": "8-K Item 5.02 (filed 2026-09-30)",
   "value": "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 1. New Equity Awards for CEO and CSO Effective September 24, 2026 (the “Grant Date”), the Compensation Committee (the “Compensation Committee”) of the Board of Directors (the “Board”) of Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) granted, upon the approval of the independent, non-employee members of the Board, a one-time award of performance share units (together, the “2026 PSUs”) under the Second Amended and Restated Regeneron Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan (the “Equity Plan”) to each of Leonard S.…",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR 8-K 0001104659-26-112340 (text as filed, excerpt)",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926112340/tm2626090d1_8k.htm",
    "filing_id": null,
    "filed_date": "2026-09-30",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "timeline",
   "label": "8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-07-30)",
   "value": "On July 30, 2026, Regeneron Pharmaceuticals, Inc. issued a press release announcing its financial and operating results for the quarter ended June 30, 2026. A copy of the press release is being furnished to the Securities and Exchange Commission as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference to this Item 2.02. The information included or incorporated in this Item 2.02, including Exhibit 99.1, shall not be deemed \"filed\" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall such information and exhibit be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be…",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC EDGAR 8-K 0000872589-26-000023 (text as filed, excerpt)",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000023/regn-20260730.htm",
    "filing_id": null,
    "filed_date": "2026-07-30",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #1 (13F as filed): BlackRock, Inc.",
   "value": 5682635642,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2012383/000201238326003238/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #2 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC",
   "value": 4133919926,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2100119/000210011926001527/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #3 (13F as filed): Dodge & Cox",
   "value": 3037348765,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/200217/000119312526349535/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #4 (13F as filed): STATE STREET CORP",
   "value": 3014621356,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/93751/000009375126000507/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #5 (13F as filed): Invesco Ltd.",
   "value": 2457161872,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/914208/000091420826000343/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #6 (13F as filed): JPMORGAN CHASE & CO",
   "value": 2384577378,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/19617/000001961726000325/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #7 (13F as filed): VANGUARD PORTFOLIO MANAGEMENT LLC",
   "value": 1979934668,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2100121/000210012126001018/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #8 (13F as filed): FRANKLIN RESOURCES INC",
   "value": 1728352744,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/38777/000003877726000222/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #9 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC",
   "value": 1632283060,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1214717/000121471726000008/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "holders",
   "label": "Largest institutional holder #10 (13F as filed): Nuveen, LLC",
   "value": 1259533994,
   "unit": "USD",
   "period_start": null,
   "period_end": "2026-06-30",
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "SEC 13F",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1871926/000093041326002447/",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "labor",
   "label": "Employer name (as filed)",
   "value": "Regeneron Pharmaceuticals, Inc.",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "DOL OFLC LCA Disclosure Data (dataset)",
    "source_url": "https://www.dol.gov/agencies/eta/foreign-labor/performance",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "labor",
   "label": "Certified LCAs",
   "value": 29,
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "DOL OFLC LCA Disclosure Data (dataset)",
    "source_url": "https://www.dol.gov/agencies/eta/foreign-labor/performance",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "labor",
   "label": "Certified LCAs later withdrawn",
   "value": 0,
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "DOL OFLC LCA Disclosure Data (dataset)",
    "source_url": "https://www.dol.gov/agencies/eta/foreign-labor/performance",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "labor",
   "label": "Total worker positions on certified LCAs",
   "value": 29,
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "DOL OFLC LCA Disclosure Data (dataset)",
    "source_url": "https://www.dol.gov/agencies/eta/foreign-labor/performance",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "labor",
   "label": "Top job titles (title, LCA count)",
   "value": "Process Development Engineer III (2); Senior Scientist (2); Director Data Management (2); Manager Central Monitoring Data Analysis (2); Senior Analytical Scientist (1)",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "DOL OFLC LCA Disclosure Data (dataset)",
    "source_url": "https://www.dol.gov/agencies/eta/foreign-labor/performance",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "labor",
   "label": "Wage offered, annualized (n, min, median, max)",
   "value": "median $155,000 (range $95,000-$250,000, 29 filings)",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "DOL OFLC LCA Disclosure Data (dataset)",
    "source_url": "https://www.dol.gov/agencies/eta/foreign-labor/performance",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "section": "labor",
   "label": "Worksite states",
   "value": "FL; NJ; NY; OH; PA; VA",
   "unit": null,
   "period_start": null,
   "period_end": null,
   "computed": false,
   "join": "id",
   "evidence": {
    "source": "DOL OFLC LCA Disclosure Data (dataset)",
    "source_url": "https://www.dol.gov/agencies/eta/foreign-labor/performance",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  }
 ],
 "changes": [
  {
   "date": "2026-11-19",
   "type": "Filing",
   "summary_as_filed": "S-8 filed (FORM S-8)",
   "freshness": "red",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926130135/tm2629628d1_s8.htm",
    "filing_id": null,
    "filed_date": "2026-11-19",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-11-05",
   "type": "Filing",
   "summary_as_filed": "13F-HR filed",
   "freshness": "amber",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926123321/xslForm13F_X02/primary_doc.xml",
    "filing_id": null,
    "filed_date": "2026-11-05",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-10-30",
   "type": "Filing",
   "summary_as_filed": "10-Q filed",
   "freshness": "amber",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000034/regn-20260930.htm",
    "filing_id": null,
    "filed_date": "2026-10-30",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-10-30",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 2.02 results of operations; Item 9.01 exhibits",
   "freshness": "amber",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000032/regn-20261030.htm",
    "filing_id": null,
    "filed_date": "2026-10-30",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-10-13",
   "type": "Filing",
   "summary_as_filed": "Form 5500 received for plan year ending 2025-12-31 (plan no. 001)",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.dol.gov/agencies/ebsa/about-ebsa/our-activities/public-disclosure/foia/form-5500-datasets",
    "filing_id": null,
    "filed_date": "2026-10-13",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-10-06",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 1.01 material agreement; Item 2.02 results of operations; Item 8.01 other event",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926113895/tm2627077d1_8k.htm",
    "filing_id": null,
    "filed_date": "2026-10-06",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-10-05",
   "type": "Filing",
   "summary_as_filed": "Form 5500 received for plan year ending 2025-12-31 (plan no. 501)",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.dol.gov/agencies/ebsa/about-ebsa/our-activities/public-disclosure/foia/form-5500-datasets",
    "filing_id": null,
    "filed_date": "2026-10-05",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-09-30",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926112340/tm2626090d1_8k.htm",
    "filing_id": null,
    "filed_date": "2026-09-30",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-08-20",
   "type": "Filing",
   "summary_as_filed": "N-PX filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926099230/xslN-PX_X01/primary_doc.xml",
    "filing_id": null,
    "filed_date": "2026-08-20",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-08-07",
   "type": "Filing",
   "summary_as_filed": "13F-HR filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926092709/xslForm13F_X02/primary_doc.xml",
    "filing_id": null,
    "filed_date": "2026-08-07",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-07-30",
   "type": "Filing",
   "summary_as_filed": "10-Q filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000025/regn-20260630.htm",
    "filing_id": null,
    "filed_date": "2026-07-30",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-07-30",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 2.02 results of operations; Item 9.01 exhibits",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000023/regn-20260730.htm",
    "filing_id": null,
    "filed_date": "2026-07-30",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-07-06",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 2.02 results of operations",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926080562/tm2619682d1_8k.htm",
    "filing_id": null,
    "filed_date": "2026-07-06",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-06-26",
   "type": "Record",
   "summary_as_filed": "latest certified decision date in the file",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.dol.gov/agencies/eta/foreign-labor/performance",
    "filing_id": null,
    "filed_date": "2026-06-26",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-06-17",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 5.07 shareholder vote",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926075127/tm2618117d1_8k.htm",
    "filing_id": null,
    "filed_date": "2026-06-17",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-05-08",
   "type": "Filing",
   "summary_as_filed": "13F-HR filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926057922/xslForm13F_X02/primary_doc.xml",
    "filing_id": null,
    "filed_date": "2026-05-08",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-04-29",
   "type": "Filing",
   "summary_as_filed": "10-Q filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000016/regn-20260331.htm",
    "filing_id": null,
    "filed_date": "2026-04-29",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-04-29",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 2.02 results of operations; Item 9.01 exhibits",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000014/regn-20260429.htm",
    "filing_id": null,
    "filed_date": "2026-04-29",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-04-24",
   "type": "Filing",
   "summary_as_filed": "ARS filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926048580/tm2611209d2_ars.pdf",
    "filing_id": null,
    "filed_date": "2026-04-24",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-04-24",
   "type": "Filing",
   "summary_as_filed": "DEFA14A filed (DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS)",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000130817926000341/a2026regeneronpharmaceutic.htm",
    "filing_id": null,
    "filed_date": "2026-04-24",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-04-24",
   "type": "Filing",
   "summary_as_filed": "DEF 14A filed (DEFINITIVE PROXY STATEMENT)",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm",
    "filing_id": null,
    "filed_date": "2026-04-24",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-04-08",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 2.02 results of operations",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926040661/tm2611354d1_8k.htm",
    "filing_id": null,
    "filed_date": "2026-04-08",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-04-01",
   "type": "Record",
   "summary_as_filed": "earliest certified decision date in the file",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.dol.gov/agencies/eta/foreign-labor/performance",
    "filing_id": null,
    "filed_date": "2026-04-01",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-02-06",
   "type": "Filing",
   "summary_as_filed": "13F-HR filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926011601/xslForm13F_X02/primary_doc.xml",
    "filing_id": null,
    "filed_date": "2026-02-06",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-02-04",
   "type": "Filing",
   "summary_as_filed": "10-K filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000008/regn-20251231.htm",
    "filing_id": null,
    "filed_date": "2026-02-04",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-01-30",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 2.02 results of operations; Item 9.01 exhibits",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258926000004/regn-20260130.htm",
    "filing_id": null,
    "filed_date": "2026-01-30",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2026-01-12",
   "type": "Filing",
   "summary_as_filed": "8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926002691/tm262861d1_8k.htm",
    "filing_id": null,
    "filed_date": "2026-01-12",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2025-11-07",
   "type": "Filing",
   "summary_as_filed": "13F-HR filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465925108546/xslForm13F_X02/primary_doc.xml",
    "filing_id": null,
    "filed_date": "2025-11-07",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2025-10-28",
   "type": "Filing",
   "summary_as_filed": "10-Q filed",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.sec.gov/Archives/edgar/data/872589/000087258925000028/regn-20250930.htm",
    "filing_id": null,
    "filed_date": "2025-10-28",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2017-09-28",
   "type": "Contract",
   "summary_as_filed": "Contract HHSO100201700016C awarded by Department of Health and Human Services, $973,560,407 obligated to date",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.usaspending.gov/award/CONT_AWD_HHSO100201700016C_7505_-NONE-_-NONE-",
    "filing_id": null,
    "filed_date": "2017-09-28",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2017-09-21",
   "type": "Contract",
   "summary_as_filed": "Contract HHSO100201700020C awarded by Department of Health and Human Services, $278,844,172 obligated to date",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.usaspending.gov/award/CONT_AWD_HHSO100201700020C_7505_-NONE-_-NONE-",
    "filing_id": null,
    "filed_date": "2017-09-21",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "2016-08-12",
   "type": "Contract",
   "summary_as_filed": "Contract HHSO100201600023C awarded by Department of Health and Human Services, $8,601,629 obligated to date",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.usaspending.gov/award/CONT_AWD_HHSO100201600023C_7505_-NONE-_-NONE-",
    "filing_id": null,
    "filed_date": "2016-08-12",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "1993-01-01",
   "type": "Record",
   "summary_as_filed": "plan effective date: REGENERON PHARMACEUTICALS, INC. 401(K) SAVINGS PLAN",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.dol.gov/agencies/ebsa/about-ebsa/our-activities/public-disclosure/foia/form-5500-datasets",
    "filing_id": null,
    "filed_date": "1993-01-01",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "date": "1990-01-01",
   "type": "Record",
   "summary_as_filed": "plan effective date: REGENERON PHARMACEUTICALS, INC. WELFARE BENEFIT PLAN",
   "freshness": "green",
   "evidence": {
    "source": "SEC EDGAR",
    "source_url": "https://www.dol.gov/agencies/ebsa/about-ebsa/our-activities/public-disclosure/foia/form-5500-datasets",
    "filing_id": null,
    "filed_date": "1990-01-01",
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  }
 ],
 "connections": [
  {
   "edge": "represented_by",
   "to_id": "sx:lda:65271",
   "to_name": "CHECKMATE GOVERNMENT RELATIONS",
   "join": "possible_match",
   "date": null,
   "evidence": {
    "source": "Senate LDA",
    "source_url": "https://seraphixsystems.com/org/sx%3Alda%3A65271",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "edge": "represented_by",
   "to_id": "sx:lda:200807",
   "to_name": "REGENERON PHARMACEUTICALS, INC",
   "join": "possible_match",
   "date": null,
   "evidence": {
    "source": "Senate LDA",
    "source_url": "https://seraphixsystems.com/org/sx%3Alda%3A200807",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "edge": "represented_by",
   "to_id": "sx:lda:210738",
   "to_name": "ARNOLD & PORTER KAYE SCHOLER LLP",
   "join": "possible_match",
   "date": null,
   "evidence": {
    "source": "Senate LDA",
    "source_url": "https://seraphixsystems.com/org/sx%3Alda%3A210738",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "edge": "represented_by",
   "to_id": "sx:lda:67618",
   "to_name": "BGR GOVERNMENT AFFAIRS",
   "join": "possible_match",
   "date": null,
   "evidence": {
    "source": "Senate LDA",
    "source_url": "https://seraphixsystems.com/org/sx%3Alda%3A67618",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "edge": "represented_by",
   "to_id": "sx:lda:208641",
   "to_name": "STEWART STRATEGIES AND SOLUTIONS, LLC",
   "join": "possible_match",
   "date": null,
   "evidence": {
    "source": "Senate LDA",
    "source_url": "https://seraphixsystems.com/org/sx%3Alda%3A208641",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "edge": "represented_by",
   "to_id": "sx:lda:64079",
   "to_name": "THE WASHINGTON TAX & PUBLIC POLICY GROUP",
   "join": "possible_match",
   "date": null,
   "evidence": {
    "source": "Senate LDA",
    "source_url": "https://seraphixsystems.com/org/sx%3Alda%3A64079",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  },
  {
   "edge": "represented_by",
   "to_id": "sx:lda:196249",
   "to_name": "an individual registrant",
   "join": "possible_match",
   "date": null,
   "evidence": {
    "source": "Senate LDA",
    "source_url": "https://seraphixsystems.com/org/sx%3Alda%3A196249",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-21T11:33:17Z",
    "content_hash": "955b79b7c9eabfda2eddfe0e972c3aa527c62b774e43d20a3b20fc82a78c582e"
   }
  }
 ],
 "screening": [
  {
   "list": "World Bank debarment list",
   "result": "not_checked",
   "matched_name": null,
   "match_basis": "not checked: link-out only; the World Bank terms allow non-commercial use only and written consent for commercial reuse has been requested",
   "list_as_of": "2026-11-22",
   "evidence": {
    "source": "World Bank",
    "source_url": "https://www.worldbank.org/en/projects-operations/procurement/debarred-firms",
    "filing_id": null,
    "filed_date": null,
    "retrieved_at": "2026-11-22T09:41:49Z",
    "content_hash": null
   }
  }
 ],
 "open_in": [
  {
   "site": "TradingView",
   "url": "https://www.tradingview.com/symbols/NASDAQ-REGN/"
  },
  {
   "site": "Yahoo Finance quote and chart",
   "url": "https://finance.yahoo.com/quote/REGN/"
  },
  {
   "site": "Google Finance",
   "url": "https://www.google.com/finance/quote/REGN:NASDAQ"
  },
  {
   "site": "Reuters search",
   "url": "https://www.reuters.com/site-search/?query=Regeneron%20Pharmaceuticals%2C%20Inc."
  },
  {
   "site": "Yahoo Finance news",
   "url": "https://finance.yahoo.com/quote/REGN/news/"
  },
  {
   "site": "Google News search",
   "url": "https://news.google.com/search?q=Regeneron%20Pharmaceuticals%2C%20Inc."
  },
  {
   "site": "Yahoo Finance analysis",
   "url": "https://finance.yahoo.com/quote/REGN/analysis/"
  },
  {
   "site": "Nasdaq earnings",
   "url": "https://www.nasdaq.com/market-activity/stocks/regn/earnings"
  },
  {
   "site": "Yahoo Finance options",
   "url": "https://finance.yahoo.com/quote/REGN/options/"
  },
  {
   "site": "Nasdaq option chain",
   "url": "https://www.nasdaq.com/market-activity/stocks/regn/option-chain"
  },
  {
   "site": "SEC EDGAR Form 4 filings",
   "url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000872589&type=4&dateb=&owner=include&count=40"
  },
  {
   "site": "OpenInsider",
   "url": "http://openinsider.com/REGN"
  },
  {
   "site": "WhaleWisdom",
   "url": "https://whalewisdom.com/stock/regn"
  },
  {
   "site": "Nasdaq short interest",
   "url": "https://www.nasdaq.com/market-activity/stocks/regn/short-interest"
  },
  {
   "site": "Search X for the company's verified account",
   "url": "https://x.com/search?q=Regeneron%20Pharmaceuticals%2C%20Inc.&f=user"
  },
  {
   "site": "World Bank debarred firms (check on the World Bank site)",
   "url": "https://www.worldbank.org/en/projects-operations/procurement/debarred-firms"
  }
 ],
 "limits": [
  "Seraphix is not a consumer reporting agency. Reports are not consumer reports and may not be used for employment, credit, insurance, housing or any FCRA purpose.",
  "No credit scores and no trade-payment data: Seraphix is not a credit bureau.",
  "Principals (officers) are role-level only until counsel rules.",
  "UCC filings, liens and bankruptcy are gaps: not covered yet.",
  "Name-matched joins are dashed possible matches until the accuracy score (due 11-21).",
  "Data is as of the stamped time on this page.",
  "Organizations only. No individuals.",
  "Court records: not covered yet",
  "UCC filings, liens, bankruptcy: not covered yet",
  "Exhibit 21 subsidiaries: not held yet",
  "WARN notices: not held yet",
  "Legislative exposure: not covered yet",
  "Principals: role-level only until counsel rules",
  "H-1B LCAs only (H-1B1 and E-3 excluded); one fiscal quarter (FY2026 Q3) only, earlier quarters not loaded",
  "Certified = status 'Certified' or 'Certified - Withdrawn' (withdrawn count shown separately)",
  "Wages are as filed, annualized from the wage unit (hour x2080, week x52, bi-weekly x26, month x12, year x1)",
  "Plan year 2025 only (EFAST2 'Latest' file); earlier years not loaded",
  "Administrator, signer and preparer names are not kept; sponsor (employer) name only",
  "Total assets shown only where the plan attached Schedule H (small plans file Schedule I or none)",
  "Participants: counts at the beginning and at the end of the plan year (end of year includes active, retired and separated participants)",
  "No Form 990 found for EIN 133444607",
  "USAspending: no grant award actions in the last 24 months",
  "USAspending: the federal figures above are for this one registration. Other registrations of the same company (for example a subsidiary) are reported separately and are not added here.",
  "SAM.gov: no active federal exclusion for UEI N3F9MH7E6HD6 (extract 2026-11-21)"
 ],
 "provenance": {
  "assembled_at": "2026-11-22T09:41:49Z",
  "sources_n": 6,
  "seconds": 0.39,
  "evidence_bundle_url": "https://seraphixsystems.com/company/872589.evidence.json",
  "bundle_hash": "6252013ca803c59a4380d10c015f8719624eab6652106105030814d345e2f4c9",
  "not_a_consumer_report": true
 }
}